Cosette Drug Patent Portfolio

Cosette owns 8 orange book drugs protected by 38 US patents with Evoxac having the least patent protection, holding only 1 patent. And Welchol with maximum patent protection, holding 26 patents. Given below is the list of Cosette's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11590209 Use of bremelanotide in patients with controlled hypertension 29 Apr, 2041
Active
US10286034 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
Active
US9352013 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
Active
US9700592 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
Active
US6794489 Compositions and methods for treatment of sexual dysfunction 28 Jun, 2025
Active
US8404703 Medicinal compositions containing aspirin 02 Jul, 2023 Expired
US8569325 Method of treatment with coadministration of aspirin and prasugrel 02 Jul, 2023 Expired
US8569325 Method of treatment with coadministration of aspirin and prasugrel 02 Jan, 2023 Expired
US7229613 Method for lowering serum glucose 17 Oct, 2022 Expired
US6878703 Pharmaceutical composition 19 May, 2022 Expired
US7229613 Method for lowering serum glucose 17 Apr, 2022 Expired
US8404703 Medicinal compositions containing aspirin 02 Mar, 2022 Expired
US6878703 Pharmaceutical composition 19 Nov, 2021 Expired
US6693115 Acid addition salts of hydropyridine derivatives 03 Jul, 2021 Expired
US6579968 Compositions and methods for treatment of sexual dysfunction 28 Jun, 2021 Expired
US5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation 14 Oct, 2017 Expired
US5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation 14 Apr, 2017 Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Oct, 2016 Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Apr, 2016 Expired
US5693675 Alkylated amine polymers 02 Jun, 2015 Expired
US5607669 Amine polymer sequestrant and method of cholesterol depletion 10 Dec, 2014 Expired
US5919832 Amine polymer sequestrant and method of cholesterol depletion 10 Dec, 2014 Expired
US6066678 Process for removing bile salts from a patient and alkylated compositions therefor 10 Dec, 2014 Expired
US6433026 Process for removing bile salts from a patient and alkylated compositions therefor 10 Dec, 2014 Expired
US5693675 Alkylated amine polymers 02 Dec, 2014 Expired
US5679717 Method for removing bile salts from a patient with alkylated amine polymers 29 Oct, 2014 Expired
US5917007 Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014 Expired
US6784254 Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014 Expired
US7101960 Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014 Expired
US5607669 Amine polymer sequestrant and method of cholesterol depletion 10 Jun, 2014 Expired
US5919832 Amine polymer sequestrant and method of cholesterol depletion 10 Jun, 2014 Expired
US6066678 Process for removing bile salts from a patient and alkylated compositions therefor 10 Jun, 2014 Expired
US6433026 Process for removing bile salts from a patient and alkylated compositions therefor 10 Jun, 2014 Expired
US5679717 Method for removing bile salts from a patient with alkylated amine polymers 29 Apr, 2014 Expired
US5917007 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014 Expired
US6784254 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014 Expired
US7101960 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014 Expired
US5340821 Composition and method for treating Sjoegren syndrome disease 07 Jul, 2013 Expired


Given below is the list of recent legal activities going on the following drug patents of Cosette.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Yr, Small Entity 19 Nov, 2023 US9352013
Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 17 Nov, 2023 US9352013
Recordation of Patent Grant Mailed 28 Feb, 2023 US11590209
Email Notification 28 Feb, 2023 US11590209
Patent Issue Date Used in PTA Calculation 28 Feb, 2023 US11590209
Issue Notification Mailed 08 Feb, 2023 US11590209
Dispatch to FDC 26 Jan, 2023 US11590209
Application Is Considered Ready for Issue 26 Jan, 2023 US11590209
Issue Fee Payment Received 24 Jan, 2023 US11590209
Issue Fee Payment Verified 24 Jan, 2023 US11590209
Email Notification 26 Oct, 2022 US11590209
Mail Notice of Allowance 26 Oct, 2022 US11590209
Electronic Review 26 Oct, 2022 US11590209
Notice of Allowance Data Verification Completed 22 Oct, 2022 US11590209
Date Forwarded to Examiner 16 Sep, 2022 US11590209


Cosette's Drug Patent Litigations

Cosette's drugs have been subject to various legal proceedings, including patent litigations. The earliest legal proceeding was initiated on Jun 26, 2015, against patent number US8569325. The petitioner Panacea Biotec Ltd., challenged the validity of this patent, with DAIICHI SANKYO COMPANY, LIMITED as the respondent. Click below to track the latest information on how companies are challenging Cosette's patents.

Patent Proceeding Filing Date Status Respondent Petitioner
Patent litigations
US8404703 March, 2015 FWD Entered
(12 Sep, 2016)
DAIICHI SANKYO COMPANY, LIMITED Accord Healthcare Inc., USA
US8404703 October, 2015 FWD Entered
(12 Sep, 2016)
Daiichi Sankyo Co., Ltd. Lupin, Ltd.
US8569325 March, 2015 FWD Entered
(12 Sep, 2016)
DAIICHI SANKYO COMPANY, LIMITED Accord Healthcare Inc., USA
US8569325 October, 2015 FWD Entered
(12 Sep, 2016)
Daiichi Sankyo Co., Ltd. Lupin, Ltd.
US8404703 June, 2015 Terminated-Denied
(07 Jan, 2016)
DAIICHI SANKYO COMPANY, LIMITED Panacea Biotec Ltd.
US8569325 June, 2015 Terminated-Denied
(07 Jan, 2016)
DAIICHI SANKYO COMPANY, LIMITED Panacea Biotec Ltd.


Cosette Drug Patents' Oppositions Filed in EPO

Cosette drug patents have faced multiple oppositions in the European Patent Office. The earliest opposition was filed on Jun 18, 2019, by Teva Pharmaceutical Industries Ltd.. This opposition was filed on patent number EP13851014A. Click below to reveal the latest opposition data.


Application Filing Date Opposition Party Legal Status
Patent litigations
EP13851014A Jun, 2019 Teva Pharmaceutical Industries Ltd. Granted and Under Opposition


Cosette's Family Patents

Cosette drugs have patent protection in a total of 26 countries. It's US patent count contributes only to 33.7% of its total global patent coverage. 5 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click below to unlock the full patent family tree.

Family Patents



Cosette Drug List

Given below is the complete list of Cosette's drugs and the patents protecting them.


1. Azor

Azor is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5616599
(Pediatric)
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Oct, 2016
(7 years ago)
Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Azor's drug page


2. Benicar

Benicar is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6878703
(Pediatric)
Pharmaceutical composition 19 May, 2022
(2 years ago)
Expired
US6878703 Pharmaceutical composition 19 Nov, 2021
(2 years ago)
Expired
US5616599
(Pediatric)
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Oct, 2016
(7 years ago)
Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar's drug page


3. Benicar Hct

Benicar Hct is protected by 4 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US6878703
(Pediatric)
Pharmaceutical composition 19 May, 2022
(2 years ago)
Expired
US6878703 Pharmaceutical composition 19 Nov, 2021
(2 years ago)
Expired
US5616599
(Pediatric)
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Oct, 2016
(7 years ago)
Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Benicar Hct's drug page


4. Effient

Effient is protected by 7 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US8404703
(Pediatric)
Medicinal compositions containing aspirin 02 Jul, 2023
(1 year, 3 months ago)
Expired
US8569325
(Pediatric)
Method of treatment with coadministration of aspirin and prasugrel 02 Jul, 2023
(1 year, 3 months ago)
Expired
US8569325 Method of treatment with coadministration of aspirin and prasugrel 02 Jan, 2023
(1 year, 9 months ago)
Expired
US8404703 Medicinal compositions containing aspirin 02 Mar, 2022
(2 years ago)
Expired
US6693115 Acid addition salts of hydropyridine derivatives 03 Jul, 2021
(3 years ago)
Expired
US5288726
(Pediatric)
Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation 14 Oct, 2017
(6 years ago)
Expired
US5288726 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof and their preparation and uses for inhibiting blood platelet aggregation 14 Apr, 2017
(7 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Effient's drug page


5. Evoxac

Evoxac is protected by 1 patent, which has expired already. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5340821 Composition and method for treating Sjoegren syndrome disease 07 Jul, 2013
(11 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Evoxac's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

6. Tribenzor

Tribenzor is protected by 2 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US5616599
(Pediatric)
Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Oct, 2016
(7 years ago)
Expired
US5616599 Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use 25 Apr, 2016
(8 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tribenzor's drug page


7. Vyleesi (autoinjector)

Vyleesi (autoinjector) is protected by 6 patents, out of which 1 has expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US11590209 Use of bremelanotide in patients with controlled hypertension 29 Apr, 2041
(16 years from now)
Active
US10286034 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
(9 years from now)
Active
US9352013 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
(9 years from now)
Active
US9700592 Uses of bremelanotide in therapy for female sexual dysfunction 05 Nov, 2033
(9 years from now)
Active
US6794489 Compositions and methods for treatment of sexual dysfunction 28 Jun, 2025
(8 months from now)
Active
US6579968 Compositions and methods for treatment of sexual dysfunction 28 Jun, 2021
(3 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Vyleesi (autoinjector)'s drug page


8. Welchol

Welchol is protected by 26 patents, out of which all have expired. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US7229613
(Pediatric)
Method for lowering serum glucose 17 Oct, 2022
(1 year, 11 months ago)
Expired
US7229613 Method for lowering serum glucose 17 Apr, 2022
(2 years ago)
Expired
US5693675
(Pediatric)
Alkylated amine polymers 02 Jun, 2015
(9 years ago)
Expired
US5607669
(Pediatric)
Amine polymer sequestrant and method of cholesterol depletion 10 Dec, 2014
(9 years ago)
Expired
US5919832
(Pediatric)
Amine polymer sequestrant and method of cholesterol depletion 10 Dec, 2014
(9 years ago)
Expired
US6066678
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 10 Dec, 2014
(9 years ago)
Expired
US6433026
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 10 Dec, 2014
(9 years ago)
Expired
US5693675 Alkylated amine polymers 02 Dec, 2014
(9 years ago)
Expired
US5679717
(Pediatric)
Method for removing bile salts from a patient with alkylated amine polymers 29 Oct, 2014
(9 years ago)
Expired
US5917007
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014
(9 years ago)
Expired
US5919832
(Pediatric)
Amine polymer sequestrant and method of cholesterol depletion 29 Oct, 2014
(9 years ago)
Expired
US6066678
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014
(9 years ago)
Expired
US6433026
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014
(9 years ago)
Expired
US6784254
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014
(9 years ago)
Expired
US7101960
(Pediatric)
Process for removing bile salts from a patient and alkylated compositions therefor 29 Oct, 2014
(9 years ago)
Expired
US5607669 Amine polymer sequestrant and method of cholesterol depletion 10 Jun, 2014
(10 years ago)
Expired
US5919832 Amine polymer sequestrant and method of cholesterol depletion 10 Jun, 2014
(10 years ago)
Expired
US6066678 Process for removing bile salts from a patient and alkylated compositions therefor 10 Jun, 2014
(10 years ago)
Expired
US6433026 Process for removing bile salts from a patient and alkylated compositions therefor 10 Jun, 2014
(10 years ago)
Expired
US5679717 Method for removing bile salts from a patient with alkylated amine polymers 29 Apr, 2014
(10 years ago)
Expired
US5917007 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014
(10 years ago)
Expired
US5919832 Amine polymer sequestrant and method of cholesterol depletion 29 Apr, 2014
(10 years ago)
Expired
US6066678 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014
(10 years ago)
Expired
US6433026 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014
(10 years ago)
Expired
US6784254 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014
(10 years ago)
Expired
US7101960 Process for removing bile salts from a patient and alkylated compositions therefor 29 Apr, 2014
(10 years ago)
Expired

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Welchol's drug page